FOSCARNET vs GANCICLOVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSCARNET vs GANCICLOVIR: Safety Overview
| Metric | FOSCARNET | GANCICLOVIR |
|---|---|---|
| Total FAERS Reports | 2,057 | 4,990 |
| Deaths Reported | 605 | 1,469 |
| Death Rate | 29.4% | 29.4% |
| Hospitalizations | 608 | 1,735 |
| Average Patient Age | 41.8 yrs | 41.7 yrs |
| % Female Patients | 40.6% | 41.5% |
| FDA Approval Date | Apr 21, 2021 | Dec 12, 1997 |
| Manufacturer | Hikma Pharmaceuticals USA Inc. | Pharmascience Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | Discontinued |